Advertisement
Home Tags Heart / Stroke-Related: High Cholesterol

Tag: Heart / Stroke-Related: High Cholesterol

The risk of cognitive decline is reduced for people age 85 years and older with high cholesterol

High Total Cholesterol Protects Against Cognitive Decline

0
Findings among elderly whose total cholesterol increased from midlife levels
For individual patients with type 2 diabetes mellitus

Treatment Effect of Fenofibrate Varies in Patients With T2DM

0
Treatment effect is greater in patients with dyslipidemia; absolute risk reduction of 2.15 percent
Prior authorization requirements are greater for proprotein convertase subtilisin/kexin type 9 inhibitors than for other cardiometabolic drugs

Greater Prior Authorization Requirements Seen for PCSK9i Rx

0
PA requirements are more extensive for PCSK9is than for other cardiometabolic drugs
For patients with autosomal recessive hypercholesterolemia

LDL-C Still High in Autosomal Recessive Hypercholesterolemia

0
Increase in use of high-intensity statin, ezetimibe; only 23.1 percent reach LDL-C of <100mg/dL
Preoperative levels of serum total cholesterol do not correlate with postoperative pain following laparoscopic surgery for gastric cancer

No Link Between Pre-Op Cholesterol, Post-Op Pain

0
Findings based on patients undergoing laparoscopic surgery for gastric cancer
Lipid-associated genetic risk correlates with the risk of abdominal aortic aneurysm

Lipid-Linked Genetic Risk Tied to Abdominal Aortic Aneurysm

0
Genetic elevation of LDL-C linked to increased AAA risk; increase for HDL-C linked to lower risk of AAA
Eating raw almonds

Almonds With/Without Chocolate May Improve Lipid Profiles

0
Findings based on a small study assessing diet combinations in overweight people
Plasma levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) may help assess apparent resistance to PCSK9 inhibitors

Measuring Plasma PCSK9 May ID Resistance to PCSK9 Inhibitors

0
Most patients experience increase of at least 3.7-fold in plasma PCSK9 levels after treatment

The American Heart Association, Nov. 11-15

0
The American Heart Association's Scientific Sessions The annual meeting of the American Heart Association was held from Nov. 11 to 15 in...
A combination of clinical factors and payer type increase the likelihood of approval for proprotein convertase subtilisin/kexin type 9 inhibitor treatment

Rate of Approval for PCSK9i Therapy 47 Percent

0
Clinical factors and payer type linked to likelihood of approval, with highest approval for Medicare